Better 3D imaging for cancer
Reconstruction-free three dimensional positron emission imaging
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-11129858
This project aims to create a new type of 3D imaging technology that could make cancer detection and staging clearer and safer for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-11129858 on ClinicalTrials.gov |
What this research studies
We are developing an advanced imaging system that uses positron emission technology (PET) to create very detailed 3D pictures without needing complex computer processing. This new approach could significantly improve how we see and understand cancer within the body. By achieving extremely precise timing measurements, the system aims to directly generate images with high clarity. This could lead to clearer images, potentially lower radiation exposure, and shorter scan times for patients.
Who could benefit from this research
Good fit: This foundational work on imaging technology does not directly involve patient participation at this stage, but future clinical applications would benefit patients undergoing cancer staging or monitoring.
Not a fit: Patients not needing advanced 3D imaging for cancer or other conditions would not directly benefit from this specific technology development.
Why it matters
Potential benefit: If successful, this new imaging method could provide more accurate cancer staging, leading to better treatment decisions and potentially reducing patient exposure to radiation during scans.
How similar studies have performed: While current PET scanners use similar principles, this project proposes a novel 'reconstruction-free' approach that represents a significant advancement over existing methods.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KWON, SUN IL — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: KWON, SUN IL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Staging